[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fMsD4jgUZqE-J0FJ7yBqtMNjA42kAJsumqgZtz0hwKH4":8,"$fy0RnxcuaiwO0SQrNxMuMw4G6bkMj6ugQ5Dp3Aaf2LKs":57,"$fkPuK5kKmrOyWyUSuC4Rd-E2BMsBp4pBSjOvd9CeAUEY":58,"$fqFeWSdi0qEKH0AyyvVXDkGSDg6yGhNM3sfqjyI45DqY":62},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":56},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"roleType":6,"adept":17,"hospital":18,"department":19,"postsTitle":20,"materialTotal":21,"videoTotal":22,"isConcern":7,"title":23,"coverVertical":17,"coverAcross":24,"directionMarker":25,"description":26,"vid":27,"time":28,"mediaType":25,"views":29,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":30,"seoTitle":31,"seoKeywords":32,"seoDescription":33,"shelvesTime":34,"menus":35,"menuId":37,"type":54,"quality":6,"commentCount":21,"isComment":25,"deviceType":22,"url":55},14238,871759,[],"https://ystcdn.venuertc.com/venue/app/24723/2026-06-16/4b86fb7a-2f8e-4922-9239-0e340dc22e9e.png","吕诗凡","","上海交通大学医学院附属仁济医院","急诊科","住院医师",0,4,"结核性胸膜炎的诊疗与管理","https://cdn.yishi-tong.com/console/3/pq31nQdg8cJHk8-Vp3WaXK9kX2-mt1_b.png",1,"WEBVTT\n\n00:02.661 --> 00:02.937\n嗯，\n\n00:02.937 --> 00:05.461\n结核性胸膜炎的诊疗与管理。\n\n00:07.471 --> 00:09.720\n我们将从以下几个方面进行展开。\n\n00:11.314 --> 00:16.215\n首先是疾病概述定义结核性胸膜炎，\n\n00:16.465 --> 00:20.815\n它是指由结核分枝杆菌感染引起的胸膜炎症，\n\n00:21.114 --> 00:23.264\n是肺外结核的常见类型，\n\n00:23.465 --> 00:26.264\n具有传染性和免疫反应性特点。\n\n00:27.250 --> 00:28.549\n胸膜的生理功能，\n\n00:29.000 --> 00:31.799\n胸膜腔是胸膜的潜在场血，\n\n00:32.150 --> 00:35.650\n正常情况下仅有少量液体起润滑作用，\n\n00:35.849 --> 00:40.599\n有助于呼吸运动时的肺脏扩张与收缩，\n\n00:40.750 --> 00:42.500\n维持呼吸功能正常。\n\n00:44.085 --> 00:47.535\n流行病学全球及我国发病情况，\n\n00:48.035 --> 00:50.335\n全球结核病负担沉重，\n\n00:50.535 --> 00:53.936\n结核性胸膜炎是肺外结核常见类型，\n\n00:54.236 --> 00:56.986\n我国是结核病高负担国家之一，\n\n00:57.236 --> 01:01.736\n其发病率与结核病情、病疫情密切相关，\n\n01:01.886 --> 01:03.285\n需加强防控。\n\n01:03.736 --> 01:04.685\n高发人群，\n\n01:05.236 --> 01:06.136\n青壮年，\n\n01:06.136 --> 01:07.460\n因活动频繁，\n\n01:07.460 --> 01:08.435\n社交广泛，\n\n01:08.435 --> 01:10.036\n免疫力低下者，\n\n01:10.185 --> 01:11.835\n如HIV感染者，\n\n01:12.136 --> 01:14.335\n长期使用免疫抑制剂患者。\n\n01:14.552 --> 01:19.501\n因免疫功能受损更易感染结核分枝杆菌是高发人群。\n\n01:21.529 --> 01:23.779\n二病因与发病机制。\n\n01:25.190 --> 01:31.190\n病原体结核分枝杆菌结核分枝杆菌是结核性胸膜炎的病原体，\n\n01:31.440 --> 01:32.940\n人型最为常见，\n\n01:32.940 --> 01:34.339\n牛型较少见。\n\n01:34.540 --> 01:37.639\n其具有耐酸碱、耐干燥等特点，\n\n01:37.639 --> 01:39.790\n可在环境中长期存活。\n\n01:42.314 --> 01:45.113\n难道是感染途径一，\n\n01:45.164 --> 01:51.138\n肺内结核病灶直接蔓延肺内结核病灶直接蔓延至胸膜，\n\n01:51.138 --> 01:53.164\n是最常见的感染途径，\n\n01:53.513 --> 01:58.564\n结核分枝杆菌通过淋巴管或直接侵入胸膜，\n\n01:58.564 --> 02:00.064\n引起炎症反应。\n\n02:00.916 --> 02:02.217\n二血型播散，\n\n02:02.616 --> 02:05.067\n血型播散是次要感染途径。\n\n02:05.317 --> 02:08.117\n全身粟粒性结核累及胸膜，\n\n02:08.466 --> 02:11.817\n结核分枝杆菌通过血液循环到达胸膜，\n\n02:11.817 --> 02:12.817\n引起炎症。\n\n02:17.684 --> 02:18.684\n发病机制。\n\n02:19.436 --> 02:27.136\n一、迟发型变态反应迟发型变态反应、4型超敏反应是结核性胸膜炎的主要发病机制，\n\n02:27.535 --> 02:31.636\n结核分枝杆菌抗原刺激胸膜引起炎症反应，\n\n02:31.785 --> 02:33.735\n导致胸膜充血、水肿。\n\n02:34.518 --> 02:41.617\n二、病理过程主要包括胸膜充血、水肿、渗出液积聚形成胸腔积液，\n\n02:41.867 --> 02:46.218\n纤维蛋白沉积可能导致胸膜粘连或肥厚，\n\n02:46.218 --> 02:47.617\n影响呼吸功能。\n\n02:50.662 --> 02:52.111\n三临床表现。\n\n02:53.697 --> 02:56.697\n症状分全身症状与局部症状。\n\n02:57.348 --> 03:04.548\n全身症状包括低热、午后较明显、盗汗、乏力、食欲减退、体重减轻等。\n\n03:04.548 --> 03:08.548\n结核中毒症状是机体对结核感染的全身反应。\n\n03:09.315 --> 03:09.966\n局部症状，\n\n03:10.266 --> 03:12.016\n局部症状包括胸痛，\n\n03:12.615 --> 03:14.291\n早期干性胸膜炎，\n\n03:14.291 --> 03:16.365\n随呼吸或咳嗽加重，\n\n03:16.716 --> 03:18.041\n积液增多时，\n\n03:18.041 --> 03:19.416\n疼痛反而减轻。\n\n03:20.016 --> 03:21.565\n第二个呼吸困难，\n\n03:21.815 --> 03:23.041\n积液量增多，\n\n03:23.041 --> 03:24.190\n压迫肺组织，\n\n03:24.190 --> 03:25.916\n表现为胸闷、气促。\n\n03:26.626 --> 03:28.727\n还有咳嗽多为干咳，\n\n03:28.727 --> 03:30.326\n因胸膜刺激引起。\n\n03:32.554 --> 03:34.953\n体征湿疹，\n\n03:35.354 --> 03:37.804\n湿疹可见患侧胸廓饱满，\n\n03:37.953 --> 03:39.753\n呼吸动度减弱。\n\n03:39.753 --> 03:43.078\n是由于胸腔积液导致胸腔内压力改变，\n\n03:43.078 --> 03:44.703\n影响呼吸运动。\n\n03:45.304 --> 03:46.404\n二、触诊，\n\n03:46.753 --> 03:49.404\n触诊时气管向健侧移位，\n\n03:49.453 --> 03:51.453\n患侧与颤减弱，\n\n03:51.654 --> 03:53.854\n因积液占据胸腔空间，\n\n03:53.854 --> 03:56.404\n影响气管位置和语音传导。\n\n03:57.248 --> 03:57.798\n扣子。\n\n03:58.940 --> 04:01.639\n叩诊患侧呈浊音或实音，\n\n04:01.839 --> 04:02.664\n用胸腔，\n\n04:02.664 --> 04:05.039\n因胸腔积液使肺组织受压，\n\n04:05.190 --> 04:06.365\n叩诊应改变，\n\n04:06.365 --> 04:08.990\n有助于判断积液量和范围。\n\n04:09.805 --> 04:10.606\n四、听诊，\n\n04:11.055 --> 04:12.955\n听诊患者呼吸音减，\n\n04:13.205 --> 04:16.205\n听诊患侧呼吸音减弱或消失。\n\n04:16.605 --> 04:19.756\n干性胸膜炎可闻及胸膜摩擦音，\n\n04:20.006 --> 04:23.506\n是由于胸膜炎症导致胸膜表面粗糙，\n\n04:23.506 --> 04:25.256\n相互摩擦产生。\n\n04:26.973 --> 04:28.324\n四辅助检查。\n\n04:30.921 --> 04:33.872\n首先是实验室检查血常规。\n\n04:34.372 --> 04:38.522\n血常规检查可见白细胞计数正常或轻度升高，\n\n04:39.071 --> 04:40.647\n淋巴细胞比例增高，\n\n04:40.647 --> 04:43.272\n提示机体存在慢性炎症反应。\n\n04:43.895 --> 04:44.746\n20乘。\n\n04:46.450 --> 04:49.100\n血沉增快是炎症活动的指标，\n\n04:49.100 --> 04:52.100\n反映机体对结核感染的免疫反应程度，\n\n04:52.399 --> 04:54.600\n有助于判断病情活动性。\n\n04:56.196 --> 05:02.196\n三、结核菌素实验结核菌素实验PPD多为强阳性，\n\n05:02.446 --> 05:03.946\n提示结核感染，\n\n05:03.946 --> 05:08.545\n但需结合临床表现和其他检查结果综合判断，\n\n05:08.545 --> 05:09.496\n避免误诊。\n\n05:10.489 --> 05:17.890\n4、伽玛干扰素释放实验IGRA辅助诊断结核感染特异性较高，\n\n05:17.890 --> 05:20.339\n可作为结核感染的筛查手段，\n\n05:20.489 --> 05:24.040\n尤其在免疫功能正常者中应用价值较高。\n\n05:27.552 --> 05:30.351\n胸腔积液检查首先是外观，\n\n05:30.802 --> 05:35.302\n胸腔积液外观呈草黄色渗出液，\n\n05:35.502 --> 05:36.902\n少数呈血性，\n\n05:37.052 --> 05:41.402\n其颜色和性质与炎症程度和病程有关，\n\n05:41.502 --> 05:43.851\n有助于初步判断积液性质。\n\n05:44.769 --> 05:45.670\n二比重。\n\n05:46.825 --> 05:48.601\n比重大于1.018，\n\n05:48.601 --> 05:50.425\n提示积液为渗出液，\n\n05:50.925 --> 05:53.726\n反映胸膜反炎症反应较重，\n\n05:53.825 --> 05:57.925\n是渗出液与漏出液鉴别的关键指标之一。\n\n05:58.276 --> 05:59.776\n3、细胞计数，\n\n06:00.325 --> 06:01.450\n白细胞增多，\n\n06:01.450 --> 06:02.950\n以淋巴细胞为主，\n\n06:02.950 --> 06:04.226\n大于50%，\n\n06:04.526 --> 06:07.675\n反映机体对结核分枝杆菌的免疫反应，\n\n06:07.876 --> 06:11.325\n有助于与其他类型胸膜腔积液鉴别。\n\n06:17.257 --> 06:19.007\n下面是胸腔积液的检查，\n\n06:19.407 --> 06:20.458\n生化方面，\n\n06:20.757 --> 06:23.108\n蛋白定量大于30g/L。\n\n06:24.015 --> 06:28.066\n或者是胸腔积液比血清蛋白比值大于零点五。\n\n06:28.615 --> 06:32.415\n第二个是乳酸脱氢酶大于200U/L，\n\n06:32.816 --> 06:38.316\n或者胸腔积液比血清乳酸脱氢酶比值大于零点六。\n\n06:38.915 --> 06:41.390\n体质提示炎症反应活跃，\n\n06:41.390 --> 06:44.716\n有助于判断积液性质和病情严重程度。\n\n06:45.446 --> 06:46.145\n病原体。\n\n06:47.657 --> 06:48.007\n嗯。\n\n06:48.964 --> 06:51.864\n胸腔积液涂片抗酸染色阳性率低。\n\n06:52.065 --> 06:54.165\n结核菌培养是金标准，\n\n06:54.165 --> 06:55.765\n但耗耗时较长。\n\n06:56.877 --> 07:00.377\nPCR检测结合DNA做快速辅助诊断，\n\n07:00.528 --> 07:02.428\n提高病原学诊断率。\n\n07:06.834 --> 07:07.834\n影像学检查。\n\n07:08.631 --> 07:09.631\n胸部X线。\n\n07:10.325 --> 07:15.075\n胸部X线检查可见少量积液时肋膈角变钝，\n\n07:15.274 --> 07:18.274\n中大量积液时患侧呈致密影，\n\n07:18.424 --> 07:20.075\n纵隔向健侧移位，\n\n07:20.075 --> 07:23.174\n是初步筛查胸腔积液的常用方法。\n\n07:23.924 --> 07:25.524\n胸部超声，\n\n07:25.924 --> 07:28.200\n胸部超声可定位胸腔积液，\n\n07:28.200 --> 07:31.174\n指导穿刺敏感度高于X线，\n\n07:31.274 --> 07:33.674\n能准确判断积液量和位置，\n\n07:33.674 --> 07:35.024\n减少穿刺风险。\n\n07:35.712 --> 07:36.712\n胸部CT，\n\n07:38.062 --> 07:46.212\n胸部CT能更清晰显示胸膜增厚、肺部原发结核病灶如肺内结节、空洞等，\n\n07:46.312 --> 07:48.261\n有助于全面评估病情，\n\n07:48.261 --> 07:49.611\n制定治疗方案。\n\n07:53.578 --> 07:55.428\n胸膜活检指征，\n\n07:56.877 --> 07:58.078\n当诊断困难，\n\n07:58.078 --> 07:59.828\n如积液检查阴性时，\n\n07:59.828 --> 08:02.678\n胸膜活检可提供病理学证据，\n\n08:02.778 --> 08:04.403\n是确诊的重要手段，\n\n08:04.403 --> 08:05.877\n有助于明确诊断。\n\n08:06.492 --> 08:06.941\n结果，\n\n08:07.492 --> 08:11.742\n胸膜组织病理可见干酪样坏死或结核肉芽肿，\n\n08:12.041 --> 08:14.441\n是确诊结核性胸膜炎的依据，\n\n08:14.541 --> 08:17.092\n为后续治疗提供准确方向。\n\n08:20.243 --> 08:22.342\n五诊断与鉴别诊断。\n\n08:23.812 --> 08:25.661\n诊断标准1病史。\n\n08:26.475 --> 08:30.575\n病史包括结核接触史、结核中毒症状等，\n\n08:30.575 --> 08:32.325\n是诊断的重要线索，\n\n08:32.424 --> 08:35.875\n有助于判断患者是否存在结核感染风险。\n\n08:37.083 --> 08:38.234\n二临床表现。\n\n08:39.742 --> 08:40.543\n以后有什么事。\n\n08:41.742 --> 08:46.442\n临床表现有胸痛、呼吸困难等症状及胸腔积液体征，\n\n08:46.692 --> 08:49.942\n结核病史可初步考虑结核性胸膜炎，\n\n08:49.942 --> 08:51.642\n需进一步检查明确。\n\n08:52.331 --> 08:53.632\n三、辅助检查，\n\n08:54.081 --> 08:57.182\n辅助检查显示胸腔积液为渗出液，\n\n08:57.281 --> 08:58.581\n淋巴细胞为主，\n\n08:58.731 --> 09:06.382\n结合PPD或者IGRA阳性或病原学或病理证实结核感染可确诊。\n\n09:08.270 --> 09:09.119\n鉴别诊断。\n\n09:11.484 --> 09:16.883\n一、细菌性胸膜炎细菌性胸膜炎如肺炎旁胸腔积液，\n\n09:17.184 --> 09:19.133\n表现为高热、脓胸，\n\n09:19.333 --> 09:22.234\n积液呈脓性中性粒细胞为主，\n\n09:22.234 --> 09:24.734\n与结核性胸膜炎有明显区别。\n\n09:25.526 --> 09:27.325\n2癌性胸腔积液。\n\n09:29.015 --> 09:31.616\n癌性胸腔积液多见于中老年人，\n\n09:31.616 --> 09:32.866\n积液多为血性，\n\n09:33.065 --> 09:36.216\n找到癌细胞或原发肿瘤证据是关键，\n\n09:36.515 --> 09:39.015\n需与结核性胸膜炎仔细鉴别。\n\n09:40.013 --> 09:42.414\n三、风湿免疫性胸膜炎，\n\n09:43.013 --> 09:46.314\n风湿免疫性胸膜炎如系统性红斑狼疮，\n\n09:46.463 --> 09:48.664\n多伴有关节痛、皮疹，\n\n09:48.713 --> 09:50.013\n自身抗体阳性，\n\n09:50.614 --> 09:52.539\n结合临床表现和检查，\n\n09:52.539 --> 09:54.713\n可与其他胸膜炎鉴别。\n\n09:56.330 --> 09:58.231\n4病毒性胸膜炎。\n\n09:58.903 --> 10:01.278\n病毒性胸膜胸膜炎病程短，\n\n10:01.278 --> 10:02.104\n可自愈，\n\n10:02.403 --> 10:03.903\n病毒检测阳性，\n\n10:04.004 --> 10:08.354\n与结核性胸膜炎在病程、病因等方面有较大差异。\n\n10:13.630 --> 10:17.679\n六治疗原则与方案首先是治疗原则。\n\n10:18.572 --> 10:19.322\n基本原则，\n\n10:19.921 --> 10:24.521\n治疗原则为早期、规律、全程、适量联合，\n\n10:24.771 --> 10:26.721\n与肺结核治疗原则相同，\n\n10:26.971 --> 10:29.572\n旨在控制感染、减少积液，\n\n10:29.572 --> 10:31.021\n防止胸膜粘连。\n\n10:31.745 --> 10:35.296\n二、治疗目标治疗目标是缓解症状，\n\n10:35.296 --> 10:36.546\n改善呼吸功能，\n\n10:36.546 --> 10:37.695\n预防并发症，\n\n10:37.695 --> 10:39.495\n提高患者生活质量，\n\n10:39.596 --> 10:40.695\n促进康复。\n\n10:43.742 --> 10:45.142\n抗结核药物治疗。\n\n10:45.991 --> 10:46.841\n治疗方案。\n\n10:47.841 --> 10:50.642\n方案为强化期加巩固期。\n\n10:51.091 --> 10:55.892\n强化期一般选用异烟肼加利福平加吡嗪酰胺，\n\n10:55.942 --> 10:59.541\n加乙胺丁醇或者链霉素治疗两个月。\n\n11:00.041 --> 11:05.442\n巩固期一般是异烟肼加利福平治疗4.7个月。\n\n11:05.541 --> 11:07.892\n总疗程是6.9个月。\n\n11:08.041 --> 11:11.041\n需要严格遵医嘱注意事项。\n\n11:11.926 --> 11:14.901\n注意事项包括监测药物不良反应，\n\n11:14.901 --> 11:17.450\n如肝肾功能、听力等，\n\n11:17.450 --> 11:18.426\n定期复查，\n\n11:18.625 --> 11:20.226\n及时调整治疗方案，\n\n11:20.226 --> 11:21.875\n确保治疗安全有效。\n\n11:28.624 --> 11:31.473\n可以进行胸腔穿刺抽液，\n\n11:31.874 --> 11:34.674\n目的目的是缓解呼吸困难，\n\n11:34.674 --> 11:36.073\n减少胸膜粘连，\n\n11:36.223 --> 11:38.049\n改善患者呼吸功能，\n\n11:38.049 --> 11:39.273\n提高生活质量，\n\n11:39.424 --> 11:41.223\n是治疗的重要环节。\n\n11:41.823 --> 11:42.424\n方法，\n\n11:42.723 --> 11:44.973\n方法为超声定位后穿刺，\n\n11:45.124 --> 11:47.523\n首次抽液不超过600ml，\n\n11:47.823 --> 11:50.223\n以后每次不超过1000ml，\n\n11:50.473 --> 11:52.299\n避免复张性肺水肿，\n\n11:52.299 --> 11:53.023\n肺水肿，\n\n11:53.124 --> 11:54.573\n确保操作安全。\n\n11:55.231 --> 11:55.781\n频率，\n\n11:56.331 --> 11:58.231\n频率根据积液量而定，\n\n11:58.231 --> 11:59.682\n每周2.3次。\n\n11:59.882 --> 12:01.781\n需密切观察患者反应，\n\n12:01.882 --> 12:04.182\n及时调整抽液频率和量。\n\n12:08.033 --> 12:09.484\n糖皮质激素应用。\n\n12:10.385 --> 12:10.935\n指征，\n\n12:11.286 --> 12:13.036\n指征为大量积液，\n\n12:13.085 --> 12:14.435\n毒性症状明显，\n\n12:14.435 --> 12:15.286\n如高热。\n\n12:15.635 --> 12:18.986\n然后需在抗结核药物基础上谨慎使用，\n\n12:19.085 --> 12:21.685\n避免单独使用导致结核扩散。\n\n12:22.806 --> 12:23.356\n作用。\n\n12:24.461 --> 12:26.611\n作用主要是减轻炎症反应，\n\n12:26.611 --> 12:27.961\n减少胸膜粘连，\n\n12:28.161 --> 12:29.611\n有助于改善病情。\n\n12:29.661 --> 12:31.911\n但需注意其可能带来的副作用，\n\n12:31.911 --> 12:33.161\n如免疫抑制等。\n\n12:33.562 --> 12:34.161\n用法，\n\n12:34.461 --> 12:36.411\n用法为泼尼松口服，\n\n12:36.512 --> 12:37.611\n逐渐减量。\n\n12:37.711 --> 12:40.611\n使用过程中需密切监测病情变化，\n\n12:40.762 --> 12:42.086\n及时调整剂量，\n\n12:42.086 --> 12:44.661\n确保治疗的效果和安全性。\n\n12:46.182 --> 12:47.031\n晋文公告诉我。\n\n12:48.882 --> 12:51.331\n七预防与预后。\n\n12:55.145 --> 12:58.245\n预后分为早期规范治疗与延误治疗。\n\n12:58.895 --> 13:01.395\n早期规范治疗效果良好，\n\n13:01.445 --> 13:02.995\n多数患者可治愈，\n\n13:03.096 --> 13:05.046\n恢复正常生活和工作，\n\n13:05.245 --> 13:07.945\n对肺功能和生活质量影响较小。\n\n13:08.346 --> 13:12.171\n而延误治疗可能出现胸膜增厚、粘连，\n\n13:12.171 --> 13:16.195\n甚至胸廓变形、肺功能下降等严重后果，\n\n13:16.296 --> 13:18.796\n增加治疗难度和康复时间。\n\n13:22.481 --> 13:23.031\n预防。\n\n13:23.481 --> 13:26.031\n预防主要包括以下四个方面，\n\n13:26.231 --> 13:27.981\n一、控制传染源。\n\n13:30.317 --> 13:32.393\n控制传染源是预防的关键，\n\n13:32.393 --> 13:35.317\n需积极治疗活动性肺结核患者，\n\n13:35.518 --> 13:39.018\n减少结核分枝杆菌在人群中的传播，\n\n13:39.018 --> 13:40.668\n降低感染风险。\n\n13:41.268 --> 13:43.117\n二、切断传播途径，\n\n13:43.617 --> 13:47.168\n切断传播途径包括戴口罩、保持通风。\n\n13:47.840 --> 13:49.890\n避免接触结核患者的飞沫，\n\n13:50.090 --> 13:53.190\n减少在人群密集场所的停留时间，\n\n13:53.390 --> 13:54.940\n降低感染机会。\n\n13:55.692 --> 13:57.591\n三保护易感人群，\n\n13:57.992 --> 13:59.242\n保护易感人群，\n\n13:59.242 --> 14:01.242\n如新生儿接种卡介苗，\n\n14:01.642 --> 14:03.692\n免疫力免疫力低下者，\n\n14:03.692 --> 14:04.716\n加强防护，\n\n14:04.716 --> 14:06.142\n提高自身免疫力，\n\n14:06.242 --> 14:07.642\n降低感染风险。\n\n14:08.041 --> 14:09.841\n四早期筛查，\n\n14:10.142 --> 14:11.166\n早期筛查，\n\n14:11.166 --> 14:13.841\n对结核高危人群定期检查，\n\n14:14.091 --> 14:16.341\n如PPD、胸部X线，\n\n14:16.492 --> 14:19.091\n有助于早期发现结核性胸膜炎，\n\n14:19.091 --> 14:20.091\n及时治疗，\n\n14:20.091 --> 14:21.142\n改善预后。\n\n14:23.650 --> 14:25.400\n八总结与展望。\n\n14:26.219 --> 14:27.219\n核心总结，\n\n14:27.820 --> 14:30.869\n胸膜炎是可防可治的结核类型，\n\n14:30.969 --> 14:34.020\n早期诊断和规范抗结核治疗是关键，\n\n14:34.270 --> 14:35.895\n可显著改善预后，\n\n14:35.895 --> 14:37.669\n提高患者生活质量。\n\n14:40.754 --> 14:42.379\n展望未来，\n\n14:42.379 --> 14:45.653\n需提高公众对结核性胸膜炎的认知，\n\n14:45.804 --> 14:47.453\n加强早期筛查，\n\n14:47.453 --> 14:49.203\n减少误诊、漏诊，\n\n14:49.354 --> 14:51.054\n同时优化治疗方案，\n\n14:51.104 --> 14:52.953\n降低药物不良反应，\n\n14:53.054 --> 14:55.754\n提高治疗效果和患者依从性，\n\n14:55.854 --> 14:58.254\n为结核病的防治贡献力量。\n\n15:00.539 --> 15:02.088\n以上是我的全部分享，\n\n15:02.088 --> 15:03.138\n感谢观看。\n\n","v0347cg10004d71ku8iljht3dqft7l60",907,523,"2026-01-26 11:59:47","快速会议记录指南 - 高效会议记录技巧与工具  \n","会议记录,快速记录,高效会议,会议技巧,会议工具,职场效率,会议管理  \n","学习如何快速高效地记录会议内容，掌握实用的会议记录技巧与工具推荐，提升职场效率与会议管理能力。适合职场人士、团队领导及会议组织者观看。","2026-04-29 17:30:00",[36],{"menuId":37,"menuName":38,"parentId":21,"orderNum":39,"path":40,"component":41,"isFrame":42,"isCache":43,"menuType":44,"visible":25,"status":21,"createDept":6,"remark":17,"createTime":45,"children":46,"columnImage":47,"columnLogo":48,"uncheckedLogo":6,"checkedLogo":6,"isHot":21,"isHome":21,"forceLogin":21,"color":6,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":40,"componentInfo":41},"1986622624134549505","科普视频",3,"video","/video.html","1","0","T","2025-11-07 10:31:58",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:40/0d7fcb56-3dc4-4dcb-99ca-a5d5c438378e.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:43/958efac7-dd02-4681-b8fd-0dd84b1bbf42.png","健康科普视频大全,了解你的健康生活","健康科普视频, 戒烟视频, 饮食健康视频, 胸痛科普, 用药知识, 职业健康视频, 贫血科普, 眼健康视频","精选健康科普视频,涵盖戒烟、胸痛、饮食、用药与职业健康等多个主题,让你轻松获取科学健康知识,提升生活质量。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:45/fa8fe113-deaa-4454-8105-d629769963dd.png","Video",2,"https://vod.haohuanjiao.com/huanjiao/specialistVideo/871759/204539e9-2e34-4794-af29-2e484c749cd9.tmp?a=0&auth_key=1789027121-ea45b465945441d4859f1c9a46af5be5-0-eea3395076c7ab2a97e351af9e753c5d&br=375&bt=375&cd=0%7C0%7C0&ch=0&cr=0&cs=0&dr=0&ds=3&eid=v0347cg10004d71ku8iljht3dqft7l60&er=0&l=20260811054334C5A390F96041B2042653&lr=&mime_type=video_mp4&net=0&pl=0&qs=13&rc=M293dDZrbztuOjczNGY3M0ApOTppZ3dtbHg0ZzMzajo2eWczNGNhcWdmci5hLS1kNDBzcy1pcW4wZWk1aDQxLS5gMS06Yw%3D%3D&vl=&vr=",true,{"code":9,"msg":55,"message":6,"data":6,"success":56},{"code":9,"msg":10,"message":6,"data":59,"success":56},{"pageNo":25,"pageSize":60,"result":61,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":63,"success":56},{"authors":64,"appraiseDimensionScoresVos":65},[],[]]